Keyphrases
Schizophrenia
100%
Atypical Antipsychotics
100%
Amisulpride
100%
Confidence Interval
90%
Risperidone
70%
Olanzapine
70%
Ziprasidone
60%
Relative Risk
50%
Second-generation Antipsychotics
30%
Akathisia
30%
People with Schizophrenia
30%
Schizophrenia Spectrum Disorders
20%
Weight Gain
20%
Continuous Data
10%
Selection Criteria
10%
Between-group
10%
No Significant Difference
10%
MEDLINE
10%
Search Methods
10%
Embase
10%
Tolerability
10%
Industrialized World
10%
Intention-to-treat
10%
Cochrane
10%
Drug Treatment
10%
Attrition Rate
10%
Random Effects Model
10%
CINAHL
10%
PsycINFO
10%
Cardiac Effects
10%
First-line Drugs
10%
Number-needed-to-treat
10%
Extrapyramidal Symptoms
10%
Quetiapine
10%
Weighted Mean Difference
10%
New Trial
10%
Aripiprazole
10%
Inefficacy
10%
Sertindole
10%
Zotepine
10%
Oral Form
10%
Extracted Data
10%
Randomized Evidence
10%
Clozapine Olanzapine
10%
Dichotomous Data
10%
Pharmacology, Toxicology and Pharmaceutical Science
Atypical Antipsychotics
100%
Amisulpride
100%
Olanzapine
80%
Randomized Controlled Trial
70%
Risperidone
70%
Ziprasidone
60%
Akathisia
30%
Tolerability
10%
Pharmacotherapy
10%
Group Trial
10%
Random Effects Model
10%
Number Needed to Treat
10%
Aripiprazole
10%
Zotepine
10%
Sertindole
10%
Clozapine
10%
Quetiapine
10%
Extrapyramidal Symptoms
10%
Antipsychotic Drug
10%
Neuroscience
Atypical Antipsychotic
100%
Amisulpride
100%
Olanzapine
80%
Risperidone
70%
Ziprasidone
60%
Akathisia
30%
Quetiapine
10%
Aripiprazole
10%
Clozapine
10%
Zotepine
10%
Sertindole
10%
Extrapyramidal Symptoms
10%
Antipsychotic
10%
Drug Therapy
10%
Agricultural and Biological Sciences
Amisulpride
100%
Confidence Interval
90%
Ziprasidone
60%
Relative Risk
50%
Weight Gain
20%
Selection Criterion
10%
Quetiapine
10%
Zotepine
10%